|
EspAddText
EspRemoveText
|
CMA 2022 Pre-Budget Submission
|
Parliamentary submission
|
2021
|
|
EspAddText
EspRemoveText
|
CMA Letter - Bill C-30 Implementation
|
Parliamentary submission
|
2021
|
|
EspAddText
EspRemoveText
|
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use
|
Policy endorsement
|
2021
|
|
EspAddText
EspRemoveText
|
National Approach to Licensure
|
Parliamentary submission
|
2021
|
|
EspAddText
EspRemoveText
|
Consensus statement on networks for high-quality rural anesthesia, surgery, and obstetric care in Canada
|
Policy endorsement
|
2021
|
|
EspAddText
EspRemoveText
|
Learning from the pandemic – Transforming and improving Quebec’s health care system
|
Parliamentary submission
|
2021
|
|
EspAddText
EspRemoveText
|
Response to “Consultation Document – Disability Tax Credit Public Consultations”
CMA Submission to Canada Revenue Agency
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Tamper Resistance under the Controlled Drugs and Substances Act
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
Proposed amendments to the marihuana for medical purposes regulations
|
Response to consultation
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-17 An Act to amend the Food and Drugs Act
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Bill C-422 An Act respecting a National Lyme Disease Strategy
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
The Health risks and harms associated with the use of marijuana
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
|
Response to consultation
|
2014
|